Filter
967
Filtered Results: 967
Text search:
Ministry
of
Health,
Pakistan
Featured
Recommendations
105
New Publications
229
Language
Document type
No document type
509
Studies & Reports
197
Guidelines
116
Manuals
76
Strategic & Response Plan
32
Training Material
16
Situation Updates
9
Fact sheets
6
Resource Platforms
3
Infographics
2
Online Courses
1
Countries / Regions
Global
79
Nepal
36
India
30
Pakistan
26
Bangladesh
22
Afghanistan
17
Myanmar / Burma
17
Nigeria
16
Asia
16
Western and Central Europe
14
Uganda
14
Kenya
12
South–East Asia Region
12
Syria
9
Africa
9
Congo, Democratic Republic of
9
Ethiopia
9
Tanzania
8
Zambia
8
Sierra Leone
7
Haiti
7
Indonesia
7
Iran
6
Zimbabwe
6
Eastern Europe
6
Liberia
6
Malawi
5
Mozambique
5
Cambodia
5
South Africa
5
Sri Lanka
5
Namibia
5
Somalia
5
Thailand
4
Ghana
4
Middle East and North Africa
4
South Sudan
4
China
3
Philippines
3
Jordan
3
Germany
3
Sudan
3
Iraq
3
Madagascar
3
Mexico
2
Ukraine
2
Rwanda
2
Laos
2
Senegal
2
Niger
2
Guinea
2
West and Central Africa
2
Lebanon
2
Vietnam
2
Yemen
2
Tajikistan
1
North Korea
1
Colombia
1
El Salvador
1
Lesotho
1
Turkey
1
Chile
1
Albania
1
Kyrgyzstan
1
Burkina Faso
1
Peru
1
Malaysia
1
Vanuatu
1
Morocco
1
Italy
1
Venezuela
1
Latin America and the Carribbean
1
Saudi Arabia
1
France
1
Maldives
1
Tunisia
1
East and Southern Africa
1
Southern Africa
1
Papua New Guinea
1
Brazil
1
Russia
1
Djibouti
1
Greece
1
Palestine
1
Georgia
1
Central African Republic
1
Mali
1
Libya
1
Bhutan
1
Botswana
1
Ecuador
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
215
Clinical Guidelines
96
Key Resources
85
Women & Child Health
73
Public Health
65
Capacity Building
22
Pharmacy & Technologies
18
Toolboxes
Mental Health
85
TB
76
Disability
75
COVID-19
73
HIV
71
Refugee
35
NTDs
27
Global Health Education
27
Natural Hazards
26
Planetary Health
26
Polio
24
Caregiver
22
Health Financing Toolbox
21
Conflict
21
Rapid Response
19
Pharmacy
19
AMR
17
NCDs
16
2.0 Rapid Response
12
Ebola & Marburg
11
Malaria
7
Cholera
6
Specific Hazards
3
Zika
2
Typhoon
1
The annual Joint Meeting of the Food and Agriculture Organization of the United Nations (FAO) Panel of Experts on Pesticide Residues in Food and the Environment and the World Health Organization (WHO) Core Assessment Group on Pesticide Residues (JMPR) was held in Rome, Italy, from 13 to 22 September...
13 May 2021
To avoid a reversal of progress from the adverse impacts of the COVID-19 pandemic, new knowledge and lessons from successful programmatic innovations are urgently needed to improve TB prevention and care. Experience can provide evidence for innovative approaches and strategies to mainta...
Addressing comorbidities and risk factors for TB is a crucial component of Pillar one of the End TB Strategy, which focuses on integrated patient-centred care and prevention, including action on TB and comorbidities. The Framework for collaborative action on TB and comorbidities aims to support coun...
The Polio Transition1
Monitoring and Evaluation (M&E) Framework was designed to monitor progress towards achieving the strategic and operational outcomes of the post-2023 Strategic Action Plan on Polio Transition (2018– 2023), as outlined in the Global Vision to use polio investments to build st...
During the first two years of the project (2019–2020), through a ‘One Health’ approach, comprehensive engagement was established with AMR coordinating committees, WHO regional and country offices and SORT IT partners in Asia, Africa, Europe and the Americas. Thirty-seven research studies were ...
July 2018
This fourth edition of the Unitaid/WHO market and technology landscape: HIV rapid diagnostic tests for self-testing report summarizes the current HIV testing gap; the challenges facing efforts to scale up; and the potential role HIV self-testing (HIVST) could play to achieve the United...
This policy brief presents a summary of current evidence on vulnerability to TB and proposes interventions for equitable, person-centred, and human rights-based TB prevention and care. It aligns with WHO policies and guidance on TB prevention and screening, management of TB and comorbidities, access...
WHO guideline on balanced national controlled medicines policies to ensure medical access and safety
Access to medicines is essential for attainment of universal health coverage, which is central to achievement of the health-related Sustainable Development Goals. Controlled medicines include those such as opioids, benzodiazepines, barbiturates, amphetamines and others with identified or emergent cl...
The second edition of the joint WHO, WIPO and WTO
publication “Promoting Access to Medical Technologies
and Innovation: Intersections between public health,
intellectual property and trade” (the Trilateral Study),*
published in 2020, included a special insert mappi...
The World Health Organization (WHO) and the global community of countries, partners, donors, technical experts, scientists and field implementation teams continue to work towards the ultimate goal of a world free of the burden of neglected tropical diseases (NTDs).
Special issue: WHO South-East Asia Journal of Public Health -Vol. 5, Issue 1, April 2016.This special This issue contains a rich collection of articles, demonstrating the encouraging scientific momentum to address the growing burden of diabetes in the region
A framework for action provides a guide for those involved in the development of the multisectoral action plan. It starts with a wide-ranging vision and, through a series of increasingly specific intentions, brings into focus actions with measurable outcomes that can be taken to achieve that vision.
Food Security And Nutrition In Emergency
recommended
Chapter 9: Public health guide for emergencies
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
Trachoma is the world’s leading infectious cause of blindness. It is one of 18 neglected
tropical diseases (NTDs) that affect over one billion of the world’s poorest people.
Significant progress has been made in the eradication of three priority diseases in the African Region, as a result of extensive collaboration between the Regional Office, WHO country offices and countries. For example, in August 2020, the region was certified free of wild poliovirus. In the area of...
The WHO laboratory biosecurity guidance follows and complements the revision of the Laboratory biosafety manual, fourth edition and provides principles and measures to prevent lapses and incidents throughout the whole value chain of handling high-consequence biological material, technology and infor...
Cholera is a major health risk in many parts of the world, affecting millions of people every year. Since mid-2021, the world has been facing an acute upsurge of the 7th cholera pandemic, which is characterized by the number, size and concurrence of multiple outbreaks, the spread to areas that had b...
Addressing comorbidities and risk factors for tuberculosis (TB) is a crucial component of the World Health Organization (WHO)’s End TB Strategy. This WHO operational handbook on tuberculosis. Module 6: tuberculosis and comorbidities aims to support countries in scaling up people-centred care, base...
